These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34879431)

  • 21. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
    Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
    Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reults of treatment with protocols BFM 90 and BFM 95].
    Sakić M; Berbić-Fazlagić J
    Med Arh; 2006; 60(6):369-72. PubMed ID: 17297851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
    Pichler H; Möricke A; Mann G; Teigler-Schlegel A; Niggli F; Nebral K; König M; Inthal A; Krehan D; Dworzak MN; Janousek D; Harbott J; Schrappe M; Gadner H; Strehl S; Haas OA; Panzer-Grümayer R; Attarbaschi A;
    Br J Haematol; 2010 Apr; 149(1):93-100. PubMed ID: 20067563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Nowak-Göttl U; Ahlke E; Fleischhack G; Schwabe D; Schobess R; Schumann C; Junker R
    Blood; 2003 Apr; 101(7):2529-33. PubMed ID: 12517808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
    Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Malhotra P; Kapoor G; Jain S; Garg B
    Indian Pediatr; 2018 Oct; 55(10):877-879. PubMed ID: 29941701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl].
    Szpecht D; Derwich K; Wachowiak J; Konatkowska B; Dworacki G
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1041-4. PubMed ID: 19531823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Janić D; Dokmanović L; Jovanović N; Skorić D; Lazić J
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():17-22. PubMed ID: 15615459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
    Pinheiro Junior ED; Pracchia LF; Beitler de Mauriño B; Martinez GA; Dorlhiac-Llacer PE; Medina AB; Velloso ED
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e7-e14. PubMed ID: 25130688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Retrospective Cohort Study.
    Dujua AC; Hernandez FG
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):e116-e123. PubMed ID: 28085747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
    Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
    Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of dose-adjusted Berlin-Frankfurt-Münster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma.
    Xie Y; Zhang Y; Zheng W; Wang X; Lin N; Tu M; Ping L; Ying Z; Zhang C; Liu W; Deng L; Song Y; Zhu J
    Med Oncol; 2015 Apr; 32(4):110. PubMed ID: 25752875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
    Zhen ZJ; Xia Y; Ling JY; Tong GL; Lin L; Cai Y; Sun XF
    Ai Zheng; 2009 Jul; 28(7):718-24. PubMed ID: 19624898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
    Mihal V; Hajduch M; Noskova V; Janostakova A; Safarova M; Orel M; Kouzmina G; Stary J; Blazek B; Pospisilova D
    Bull Cancer; 2004 Apr; 91(4):E80-9. PubMed ID: 15562558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.
    Buendia MT; Terselich G; Lozano JM; Viscaino MP
    Med Pediatr Oncol; 1997 Feb; 28(2):108-16. PubMed ID: 8986146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia.
    Saburi M; Ogata M; Soga Y; Itani K; Kohno K; Nakayama T
    Intern Med; 2020 Jul; 59(14):1745-1748. PubMed ID: 32296003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.